BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. ✅
Go to Publication ✅
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21 Pub: 2015 Apr Epub: Authors Shadnoush M , Hosseini RS , Khalilnezhad A , Navai L , Goudarzi H , Vaezjalali M , |
|
|
Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: Issue Pages: Pub: 2020 Nov 22 Epub: 2020 Nov 22 Authors Xu H , Ma C , Zhao F , Chen P , Liu Y , Sun Z , Cui L , Kwok LY , Zhang H , |
|
|
Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome. ✅
Go to Publication ✅
Microbiology spectrum (Microbiol Spectr ) Vol: Issue Pages: e0085921 Pub: 2021 Oct 6 Epub: 2021 Oct 6 Authors Liu A , Ma T , Xu N , Jin H , Zhao F , Kwok LY , Zhang H , Zhang S , Sun Z , |
|
|
Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice. ✅
Microorganisms (Microorganisms ) Vol: 9 Issue 10 Pages: Pub: 2021 Oct 3 Epub: 2021 Oct 3 Authors Wang N , Wang S , Xu B , Liu F , Huo G , Li B , |
|
|
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , |
|
|
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , |
|
|
Effects of a formula with a probiotic Bifidobacterium lactis Supplement on the gut microbiota of low birth weight infants. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 59 Issue 4 Pages: 1493-1503 Pub: 2020 Jun Epub: 2019 Jun 13 Authors Chi C , Xue Y , Liu R , Wang Y , Lv N , Zeng H , Buys N , Zhu B , Sun J , Yin C , |
|
|
Effects of a formula with a probiotic Bifidobacterium lactis Supplement on the gut microbiota of low birth weight infants. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 59 Issue 4 Pages: 1493-1503 Pub: 2020 Jun Epub: 2019 Jun 13 Authors Chi C , Xue Y , Liu R , Wang Y , Lv N , Zeng H , Buys N , Zhu B , Sun J , Yin C , |
|
|
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. ✅
Journal of clinical microbiology (J Clin Microbiol ) Vol: 44 Issue 11 Pages: 4025-31 Pub: 2006 Nov Epub: 2006 Sep 13 Authors Mohan R , Koebnick C , Schildt J , Schmidt S , Mueller M , Possner M , Radke M , Blaut M , |
|
|
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. ✅
Journal of clinical microbiology (J Clin Microbiol ) Vol: 44 Issue 11 Pages: 4025-31 Pub: 2006 Nov Epub: 2006 Sep 13 Authors Mohan R , Koebnick C , Schildt J , Schmidt S , Mueller M , Possner M , Radke M , Blaut M , |
|
|
Effects of Bifidobacterium animalis subsp. lactis IU100 on Immunomodulation and Gut Microbiota in Immunosuppressed Mice. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 3 Pages: Pub: 2024 Feb 29 Epub: 2024 Feb 29 Authors Zhou L , Yin X , Fang B , He J , Zhan J , Zhang X , Wang R , |
|
|
Effects of Bifidobacterium animalis subsp. lactis IU100 on Immunomodulation and Gut Microbiota in Immunosuppressed Mice. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 3 Pages: Pub: 2024 Feb 29 Epub: 2024 Feb 29 Authors Zhou L , Yin X , Fang B , He J , Zhan J , Zhang X , Wang R , |
|
|
Effects of Bifidobacterium animalis subsp. lactis IU100 on Immunomodulation and Gut Microbiota in Immunosuppressed Mice. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 3 Pages: Pub: 2024 Feb 29 Epub: 2024 Feb 29 Authors Zhou L , Yin X , Fang B , He J , Zhan J , Zhang X , Wang R , |
|
|
Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 3 Pages: Pub: 2024 Jan 24 Epub: 2024 Jan 24 Authors Gan L , Wang Y , Huang S , Zheng L , Feng Q , Liu H , Liu P , Zhang K , Chen T , Fang N , |
|
|
Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 3 Pages: Pub: 2024 Jan 24 Epub: 2024 Jan 24 Authors Gan L , Wang Y , Huang S , Zheng L , Feng Q , Liu H , Liu P , Zhang K , Chen T , Fang N , |
|
|
Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 5 Pages: 2585-2597 Pub: 2024 Feb 7 Epub: 2024 Jan 29 Authors Liang X , Zheng X , Wang P , Zhang H , Ma Y , Liang H , Zhang Z , |
|
|
Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 5 Pages: 2585-2597 Pub: 2024 Feb 7 Epub: 2024 Jan 29 Authors Liang X , Zheng X , Wang P , Zhang H , Ma Y , Liang H , Zhang Z , |
|
|
Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 5 Pages: 2585-2597 Pub: 2024 Feb 7 Epub: 2024 Jan 29 Authors Liang X , Zheng X , Wang P , Zhang H , Ma Y , Liang H , Zhang Z , |
|
|
Bifidobacterium animalis subsp. lactis BL-99 ameliorates colitis-related lung injury in mice by modulating short-chain fatty acid production and inflammatory monocytes/macrophages. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 2 Pages: 1099-1112 Pub: 2023 Jan 23 Epub: 2023 Jan 23 Authors Nan X , Zhao W , Liu WH , Li Y , Li N , Hong Y , Cui J , Shang X , Feng H , Hung WL , Peng G , |
|
|
Wheat-durum pasta added of inactivated Bifidobacterium animalis decreases glucose and total cholesterol levels and modulates gut microbiota in healthy rats. ✅
Go to Publication ✅
International journal of food sciences and nutrition (Int J Food Sci Nutr ) Vol: 72 Issue 6 Pages: 781-793 Pub: 2021 Sep Epub: 2021 Jan 24 Authors Almada CN , Almada-Érix CN , Costa WKA , Graça JS , Cabral L , Noronha MF , Gonçalves AESS , Santos AD , Lollo PC , Magnani M , Sant'Ana AS , |
|
|
Synergistic defecation effects of Bifidobacterium animalis subsp. lactis BL-99 and fructooligosaccharide by modulating gut microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 15 Issue Pages: 1520296 Pub: 2024 Epub: 2025 Jan 9 Authors Zhang Q , Zhao W , Luo J , Shi S , Niu X , He J , Wang Y , Zeng Z , Jiang Q , Fang B , Chen J , Li Y , Wang F , He J , Guo J , Zhang M , Zhang L , Ge S , Hung WL , Wang R , |
|
|
Synergistic defecation effects of Bifidobacterium animalis subsp. lactis BL-99 and fructooligosaccharide by modulating gut microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 15 Issue Pages: 1520296 Pub: 2024 Epub: 2025 Jan 9 Authors Zhang Q , Zhao W , Luo J , Shi S , Niu X , He J , Wang Y , Zeng Z , Jiang Q , Fang B , Chen J , Li Y , Wang F , He J , Guo J , Zhang M , Zhang L , Ge S , Hung WL , Wang R , |
|
|
Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3-2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Dec 21 Epub: 2024 Dec 21 Authors Zheng X , Zhang Z , Shan T , Zhao M , Lu H , Zhang L , Liang X , |
|
|
Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3-2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Dec 21 Epub: 2024 Dec 21 Authors Zheng X , Zhang Z , Shan T , Zhao M , Lu H , Zhang L , Liang X , |
|
|
Bifidobacterium animalis Supplementation Improves Intestinal Barrier Function and Alleviates Antibiotic-Associated Diarrhea in Mice. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 14 Issue 10 Pages: Pub: 2025 May 11 Epub: 2025 May 11 Authors Du X , Liu M , Li J , Liu Y , Ge S , Gao H , Zhang M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
